Drugs / mometasone fluoridate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07675512 Comparator | Jan → Aug 2025 | chronic rhinosinusitis | University of Campania Luigi Vanvitelli | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mometasone fluoridate | “The patients in the control group will be treated by Nasonex (mometasone fluoridate) ( 1 puff for nary two time a day )and nasal irrigation two times a day (morning ad evening)” NCT07675512 ↗ |
| Known as | Nasonex | “The patients in the control group will be treated by Nasonex (mometasone fluoridate) ( 1 puff for nary two time a day )and nasal irrigation two times a day (morning ad evening)” NCT07675512 ↗ |